SEMA6B has been demonstrated to have a critical role in the prognosis of various tumors, such as gliomas (Sun et al., 2019), breast cancer (Murad et al., 2006) and testicular cancer (Ji et al., 2020). Here, SEMA6B is linked to breast carcinoma.